Armistice Capital, LLC Pacira Bio Sciences, Inc. Transaction History

Armistice Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $11.5 Million - $17.2 Million	300,000 Added 18.84%	1,892,000 $73.1 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $51.2 Million - $58.9 Million	1,000,000 Added 168.92%	1,592,000 $84.7 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $3.5 Million - $5.55 Million	68,000 Added 12.98%	592,000 $34.5 Million
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $47.3 Million - $60.3 Million	-788,000 Reduced 60.06%	524,000 $40 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $18 Million - $23.4 Million	376,000 Added 40.17%	1,312,000 $78.9 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $51.1 Million - $57.4 Million	936,000 New	936,000 $52.4 Million
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $39.2 Million - $51.4 Million	-1,072,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $39.1 Million - $45.2 Million	1,072,000 New	1,072,000 $40.8 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $20 Million - $28.9 Million	-726,671 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $12 Million - $18.5 Million	398,671 Added 121.55%	726,671 $22.6 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $1.27 Million - $1.88 Million	40,000 Added 13.89%	328,000 $15 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $10.3 Million - $11.4 Million	288,000	288,000 $10.8 Million

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.08B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.